|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.055 USD | -0.49% |
|
-11.00% | -4.89% |
| 06-29 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 161M 141M 131M 121M 226M 15.35B 230M 1.56B 610M 7.61B 603M 590M 26.3B | P/E 2026 * |
-1.71x | P/E 2027 * | -2.04x |
|---|---|---|---|---|---|
| Enterprise Value | 414M 363M 338M 311M 583M 39.52B 593M 4.01B 1.57B 19.6B 1.55B 1.52B 67.72B | EV / Sales 2026 * |
2.99x | EV / Sales 2027 * | 1.08x |
| Free-Float |
95.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Karyopharm Therapeutics Inc.
| 1 day | -1.62% | ||
| 1 week | -11.00% | ||
| Current month | -28.35% | ||
| 1 month | -30.59% | ||
| 3 months | -18.60% | ||
| 6 months | +1.16% | ||
| Current year | -4.89% |
| 1 week | 6.75 |  | 8.02 |
| 1 month | 6.48 | | 10.86 |
| Current year | 5 | | 10.99 |
| 1 year | 3.65 | | 10.99 |
| 3 years | 3.51 | | 29.25 |
| 5 years | 3.51 | | 220.95 |
| 10 years | 3.51 | | 444.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 58 | 02/05/2021 |
Lori Macomber
DFI | Director of Finance/CFO | 55 | 02/01/2025 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Barry Greene
BRD | Director/Board Member | 62 | 31/12/2012 |
| Director/Board Member | 61 | 31/03/2013 | |
Garen Bohlin
BRD | Director/Board Member | 78 | 02/10/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21/05/26 | Free | Director | 15,508 | 0.0688% | ||
| 21/05/26 | Free | Director | 15,508 | 0.0688% | ||
| 21/05/26 | Free | Director | 15,508 | 0.0688% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.48% | -11.00% | +60.18% | -74.07% | 161M | |
| +3.26% | +1.84% | +23.09% | -7.84% | 67.88B | |
| +1.79% | +2.58% | +39.89% | +213.85% | 53.23B | |
| +0.26% | +54.90% | +54.90% | +54.90% | 48.71B | |
| +2.69% | -2.52% | -55.39% | -55.35% | 38.98B | |
| +1.16% | -0.38% | +56.54% | -23.70% | 29.55B | |
| +8.24% | +11.39% | +86.37% | +107.26% | 23.75B | |
| -0.73% | -7.29% | +63.11% | -53.39% | 22.07B | |
| +0.62% | -2.81% | +0.84% | +162.10% | 19.84B | |
| +0.60% | +0.39% | +65.65% | +126.60% | 16.57B | |
| Average | +1.61% | -0.15% | +39.52% | +45.04% | 32.07B | |
| Weighted average by Cap. | +2.05% | +1.30% | +32.53% | +54.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 138M 121M 113M 104M 195M 13.2B 198M 1.34B 525M 6.55B 519M 508M 22.62B | 149M 131M 122M 112M 210M 14.23B 214M 1.44B 565M 7.06B 559M 547M 24.39B |
| Net income | -116M -102M -95.11M -87.48M -164M -11.12B -167M -1.13B -442M -5.51B -437M -427M -19.05B | -142M -125M -116M -107M -200M -13.57B -204M -1.38B -539M -6.73B -533M -522M -23.25B |
| Net Debt | 253M 222M 207M 190M 356M 24.17B 363M 2.45B 960M 11.99B 950M 929M 41.42B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/07/26 | US$6.960 | -1.83% | 188,747 |
| 27/07/26 | US$7.090 | -4.32% | 527,473 |
| 24/07/26 | US$7.410 | +4.51% | 900,248 |
| 23/07/26 | US$7.090 | -1.25% | 680,130 |
| 22/07/26 | US$7.180 | -8.71% | 713,636 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KPTI Stock
Select your edition
All financial news and data tailored to specific country editions
